For the quarter ending 2026-03-31, TTRX has $18,644,136 in assets. $12,526,588 in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 11,217,671 | 5,076,144 | 3,106,157 | |
| Prepaid expenses and other current assets | 235,171 | 120,300 | 188,583 | |
| Total current assets | 11,452,842 | 5,196,444 | 3,294,740 | |
| Right-of-use asset | 67,573 | 78,620 | 89,423 | |
| Intangible assets, net | 919,947 | 922,171 | 904,885 | |
| Deferred offering cost | 6,195,192 | 5,956,424 | - | |
| Security deposit | 8,582 | 8,582 | 8,582 | |
| Total assets | 18,644,136 | 12,162,241 | 4,297,630 | |
| Accounts payable and accrued expenses | 2,315,265 | 2,928,728 | 2,264,425 | |
| Derivative liability instruments | 2,767,462 | 3,028,401 | - | |
| Current portion of operating lease liability | 47,795 | 46,295 | 44,829 | |
| Total current liabilities | 5,130,522 | 6,003,424 | 2,309,254 | |
| Operating lease liability, net of current portion | 21,539 | 34,081 | 46,344 | |
| Long-term debt, net | 5,936,514 | - | - | |
| Deferred revenue | 1,438,013 | 1,438,013 | 1,438,013 | |
| Total liabilities | 12,526,588 | 7,475,518 | 3,793,611 | |
| Common stock, 0.0001 par value, 500 million shares authorized at march 31, 2026 and december 31, 2025 29,788,040 and 29,445,183 shares issued at march 31, 2026 and december 31, 2025, respectively | 2,977 | 2,943 | 2,802 | |
| Additional paid-in capital | 29,475,636 | 28,143,873 | 23,223,079 | |
| Subscription receivable | - | 1,070,000 | 52,699 | |
| Accumulated deficit | -23,361,065 | -22,390,093 | -22,669,163 | |
| Total stockholders equity | 6,117,548 | 4,686,723 | 504,019 | |
| Total liabilities and stockholders equity (deficit) | 18,644,136 | 12,162,241 | 4,297,630 | |
Turn Therapeutics Inc. (TTRX)
Turn Therapeutics Inc. (TTRX)